XBIT

XBiotech Inc. XBIT

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 39 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-6.73M

Quarter to Jun 30

Free cash flow

$-4.51M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$4.56M total
BlackRock, Inc.
$738.6K+9.6%
GEODE CAPITAL MANAGEMENT, LLC
$492.8K-7.3%
VANGUARD CAPITAL MANAGEMENT LLC
$460.4K-0.4%
RBF Capital, LLC
$456.6K0.0%
MORGAN STANLEY
$340.1K-10.7%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$226.4K0.0%
VANGUARD FIDUCIARY TRUST CO
$212.4K+0.9%
MILLENNIUM MANAGEMENT LLC
$182.5K-24.8%
STATE STREET CORP
$167.9K0.0%
NORTHERN TRUST CORP
$152.4K-12.9%
Empowered Funds, LLC
$137.0K0.0%
RENAISSANCE TECHNOLOGIES LLC
$95.8K+85.7%
Bank of New York Mellon Corp
$90.5K0.0%
DIMENSIONAL FUND ADVISORS LP
$83.0K0.0%
Squarepoint Ops LLC
$79.9K-15.7%
Qube Research & Technologies Ltd
$77.2K+79.6%
GSA CAPITAL PARTNERS LLP
$71.0KNew
CITADEL ADVISORS LLC
$67.1KNew
Connor, Clark & Lunn Investment Management Ltd.
$64.3K-2.5%
BNP PARIBAS FINANCIAL MARKETS
$60.9K-2.6%
NATIONAL BANK OF CANADA /FI/
$57.5K0.0%
BANK OF AMERICA CORP /DE/
$54.7K-35.2%
AMERICAN CENTURY COMPANIES INC
$42.3K-2.6%
Thomasville National Bank
$30.7K--
XTX Topco Ltd
$30.1K-26.9%
See all 36 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/XBIT

Earnings Per Share

13fpro.ai/company/XBIT

Loading ratio trend…

XBIT key financials by period

Reported revenue, net income and operating margin by fiscal year, from XBiotech Inc.'s annual filings on SEC EDGAR.

XBiotech Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2022$4.0M$-32.9M—
FY 2021$18.4M$-17.4M-136.4%
FY 2020$44.0M$-11.2M-41.5%
Source: XBIT filings on SEC EDGAR →

About XBiotech Inc. (XBIT): stock profile, AI score and financials

XBiotech Inc. (XBIT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. XBIT is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 39 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q2 2026), XBiotech Inc. reports net income of $-6.7M, free cash flow of $-4.5M. Top institutional holders of XBIT by reported 13-F value include BlackRock, GEODE CAPITAL MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. XBIT trades on the Nasdaq exchange and files with the SEC under CIK 1626878. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate XBIT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for XBiotech Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1626878 →